Provided by Tiger Fintech (Singapore) Pte. Ltd.

ESSA Pharma

1.73
-0.0400-2.26%
Post-market: 1.730.00000.00%16:08 EDT
Volume:225.80K
Turnover:392.40K
Market Cap:76.79M
PE:-2.47
High:1.78
Open:1.77
Low:1.72
Close:1.77
Loading ...
Oct 31, 2022

Major Issues Report

8-K - Current report
Oct 27, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 26, 2022

Major Issues Report

8-K - Current report
Sep 13, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 12, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 27, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2022

Major Issues Report

8-K - Current report
Mar 10, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 12, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership